DGAP-News: STADA to establish logistics and distribution center in Dubai
(firmenpresse) - DGAP-News: STADA Arzneimittel AG / Key word(s): Miscellaneous
STADA to establish logistics and distribution center in Dubai
21.03.2013 / 09:30
---------------------------------------------------------------------
STADA to establish logistics and distribution center in Dubai
Growth region MENA receives its own supply hub
Bad Vilbel/Dubai, March 21, 2013 - STADA Arzneimittel AG will establish a
logistics and distribution center for the Middle East and North Africa
(MENA region) in Dubai within the current year. In the future, all
countries of the region where STADA is active will be supplied with
products from the German pharmaceutical manufacturer via the central supply
hub. For this purpose, it is planned to found a subsidiary in Dubai. The
new sales organization will be built up in the third and fourth quarters of
2013 in cooperation with a local partner. STADA will be able to draw on the
already established infrastructure of the partner company.
'With this project, we are taking account of the increased sales in the
MENA region and, at the same time, we are efficiently positioning ourselves
for future developments in this growth market', says Hartmut Retzlaff,
Chairman of the Executive Board of STADA Arzneimittel AG. 'We are bundling
the previously locally organized sales activities of the respective
countries in the region and thereby delivering our products
cost-effectively and even quicker to the customers. We also expect
significantly better regulatory framework conditions and advantages in the
approval of new products as a result of a local logistics hub.' Due to the
good economic framework conditions, Dubai is considered the ideal location
for the project.
In addition to generics, branded products in particular are the sales
drivers of the region for STADA. The strongest countries according to sales
include Saudi Arabia and the United Arab Emirates, among others.
About STADA Arzneimittel AG:
STADA Arzneimittel AG is a publicly-listed company with headquarters in Bad
Vilbel, Germany. STADA consistently focuses on a multi-pillar strategy of
generics and branded products (OTC) with an increasingly international
market orientation. The Group traditionally has a strong presence in Europe
and is the only independent generics producer in Germany. Worldwide, STADA
is one of the five leading companies in the generics industry and is
represented in more than 30 countries with approximately 50 subsidiaries.
Branded products such as Mobilat, Grippostad and Ladival are among the
highest selling in their product category in Germany. In financial year
2012, STADA achieved Group sales of Euro 1,837.5 million, adjusted earnings
before interest, taxes, depreciation and amortization (EBITDA) of Euro
367.5 million and adjusted net income of Euro 147.9 million. As of December
31, 2012, STADA employed 7,761people worldwide.
For more information, please contact:
STADA Arzneimittel AG
Media Relations
D-61118 Bad Vilbel
Tel.: +49(0) 6101 603-165
Fax: +49(0) 6101 603-506
e-mail: press(at)stada.de
End of Corporate News
---------------------------------------------------------------------
21.03.2013 Dissemination of a Corporate News, transmitted by DGAP - a
company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive atwww.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------
Language: English
Company: STADA Arzneimittel AG
Stadastraße 2-18
61118 Bad Vilbel
Germany
Phone: +49 (0)6101 603- 113
Fax: +49 (0)6101 603- 506
E-mail: communications(at)stada.de
Internet: www.stada.de
ISIN: DE0007251803, DE0007251845,
WKN: 725180, 725184,
Indices: MDAX
Listed: Regulierter Markt in Düsseldorf, Frankfurt (Prime
Standard); Freiverkehr in Berlin, Hamburg, Hannover,
München, Stuttgart
End of News DGAP News-Service
---------------------------------------------------------------------
204613 21.03.2013
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 21.03.2013 - 09:30 Uhr
Sprache: Deutsch
News-ID 241686
Anzahl Zeichen: 16921
contact information:
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 215 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"DGAP-News: STADA to establish logistics and distribution center in Dubai"
steht unter der journalistisch-redaktionellen Verantwortung von
STADA Arzneimittel AG (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
